HighTide Therapeutics, Inc. (2511.HK), a clinical stage biopharmaceutical company specializing in the development of multifunctional multi-targeted therapies for metabolic diseases, announced that data from the Phase 3 SYMPHONY 2 trial evaluating the safety and efficacy of HTD1801 in patients with type 2 diabetes mellitus (T2DM) is being presented at the 61st Annual Meeting of the European Association for the Study of Diabetes (EASD) in Vienna.
More info..

Mitsubishi Motors Corporation (hereafter, Mitsubishi Motors) announced that Mitsubishi Motors Europe B.V., Mitsubishi Motors' subsidiary in Europe, will begin a sequential launch of the all-new Eclipse Cross battery electric vehicle (hereafter, BEV) for the European market before the end of 2025.
More info..

Mitsubishi Motors Corporation (hereafter, Mitsubishi Motors) will begin sales of the fully redesigned Delica Mini and eK Space super height-wagon kei-cars1 at dealerships across Japan on October 29.
More info..

TOYOTA GAZOO Racing (TGR) unveiled a partially upgraded GR Corolla today and announced that orders are now being accepted at Toyota vehicle dealers across Japan, with sales to commence on November 3.
More info..

Honda will exhibit Honda Koraidon, a future mobility concept, at the Honda Collection Hall during the 2025 FIM*1 MotoGP World Championship Round 17, the MOTUL Grand Prix of Japan (Japanese GP), to be held at Mobility Resort Motegi (Tochigi Prefecture) from Friday, September 26 to Sunday, September 28*2.
More info..

Mitsubishi Motors Corporation (hearafter, Mitsubishi Motors) announced today that it has increased its equity stake in FleetPartners Group Limited (hereafter, FleetPartners), a leading automotive financial services company in Australia and New Zealand, to 19.93% as of September 17.
More info..

Mitsubishi Heavy Industries, Ltd. (MHI) has recently been awarded a contract from Japan's National Institutes for Quantum Science and Technology (QST) to manufacture 20 units of outer vertical targets, which are critical components of divertors, for ITER(*1,*2), the experimental fusion reactor currently under construction in southern France.
More info..

NTT, Inc. (Headquarters: Chiyoda, Tokyo; President and CEO: Akira Shimada; hereinafter "NTT") and Mitsubishi Heavy Industries, Ltd. (Headquarters: Chiyoda, Tokyo; President and CEO: Eisaku Ito; hereinafter "MHI") conducted an optical wireless power transmission experiment using laser beam to wirelessly transmit energy 1 kilometer away.
More info..

NeoLoad Web 新バージョン テクノロジーが進化するにつれ、テストソリューションも進化する必要があります。NeoLoad Web はすでにモダンなプラットフォームでしたが、解決すべき制限がありました。本リリースでは、NeoLoad Web の次世代版を正式に提供開始します。
More info..

Hondaは、2025年10月に「VEZEL（ヴェゼル）」に追加予定の新グレード「VEZEL e:HEV RS（ヴェゼル イーエイチイーブイ アールエス）」に関する情報を、本日ホームページで先行公開しました。　
More info..

More info..

Mitsubishi Corporation ("MC") is pleased to announce that Anglo American Sur S.A. ("AAS"), in which MC holds a 20.4% stake, has entered into a definitive agreement with Codelco to implement a joint mine plan for their adjacent copper operations in Chile: Los Bronces and Andina. This agreement builds on the memorandum of understanding announced in February 2025.
More info..

Eisai Co., Ltd. (Headquarters: Tokyo, CEO: Haruo Naito, "Eisai") announced today that etalanetug (development code: E2814), an investigational anti-MTBR (microtubule binding region) tau antibody, was granted Fast Track designation by the U.S. Food and Drug Administration (FDA).
More info..

Honda has unveiled its first electric motorcycle, "Honda WN7," in Europe.
More info..

NTT株式会社（本社：東京都千代田区、代表取締役社長：島田 明、以下「NTT」）と三菱重工業株式会社（本社：東京都千代田区、代表取締役社長：伊藤 栄作、以下「三菱重工」）は、レーザ光を用いて1km先にワイヤレスでエネルギーを供給する光無線給電実験を実施しました。
More info..

富士通株式会社（以下、富士通）と日本アイ・ビー・エム株式会社（以下、日本IBM）は、日本が抱える様々な社会課題を先進的なテクノロジーを活用して解決し、より良い社会の実現を目指すことを目的に、両社が有するテクノロジーや知見を組み合わせ、共創を通じて、新しい価値の創出で変革を加速するため、日本市場における「AI」「ハイブリッドクラウド」「ヘルスケア」の領域において協業を検討することに合意しました。
More info..

HighTide Therapeutics, Inc. (2511.HK), a clinical stage biopharmaceutical company specializing in the development of multifunctional multi-targeted therapies for metabolic diseases, announced that data from the Phase 3 SYMPHONY 2 trial evaluating the safety and efficacy of HTD1801 in patients with type 2 diabetes mellitus (T2DM) is being presented at the 61st Annual Meeting of the European Association for the Study of Diabetes (EASD) in Vienna.
More info..

世界的な投資会社であるKKRは、本日、KKRが運用するファンドが、プライベートエクイティスポンサーである株式会社アドバンテッジパートナーズ（以下、「AP」）がサービスを提供するファンドから、株式会社保険見直し本舗グループ（以下、「保険見直し本舗グループ」）の買収を完了したことをお知らせいたします。
More info..

Honda R&D Co., Ltd. (Honda) today announced that it has developed a new "chemical sorting" technology, which sorts and extracts reusable plastics from waste plastic parts that contain solid contaminants unique to automotive waste.
More info..